Sequent Scientific Ltd gets Form 483 with One Observation from USFDA for Vizag facility

The United States Food and Drug Administration (USFDA) had an inspection of Sequent Scientific Limited's manufacturing facility situated at Visakhapatnam, Andhra Pradesh from September 18, 2023 to September 22, 2023. At the end of the inspection, we have been issued a Form 483 with one observation. The observation is procedural in nature. We will respond to the USFDA within the stipulated timeline and work closely with them to address the observation at the earliest.

The Company remains committed to maintaining the highest standards of quality, safety and compliance.

Shares of Sequent Scientific Limited was last trading in BSE at Rs. 88.39 as compared to the previous close of Rs. 88.67. The total number of shares traded during the day was 23295 in over 249 trades.

The stock hit an intraday high of Rs. 89.33 and intraday low of 87.04. The net turnover during the day was Rs. 2051741.00.

Source : Equity Bulls

Keywords

SequentScientific INE807F01027 USFDA Inspection Form483 1Observation